Moussa et al. found that the immunopositive rate of pSmad2/3 and Smad4, which are the cellular inflammatory factors, increased with the degree of chronic hepatitis C, liver fibrosis, and liver cancer by the study on patients with chronic hepatitis C, liver cancer patients, and normal controls [97]. The gene discussed is SMAD4; the disease is liver cancer.